Background
Studies have thus far neglected to evaluate the impact of the da Vinci single port (SP) robotic platform on surgeon experience and operating room efficiency. We sought to assess the effect of the SP platform on surgeon cognitive load measures during robotic assisted laparoscopic prostatectomy (RALP).
Methods
We prospectively compared the first 20 SP‐RALPs performed at our institution to 20 multi‐port (MP)‐RALPs performed by a single experienced robotic surgeon. Three multi‐dimensional assessment tools were used to evaluate mental and surgical workload, teamwork and workflow disruptions.
Results
No statistically significant differences were found between the MP‐RALP and SP‐RALP cohorts when evaluated by NASA Task Load Index, Surgery Task Load Index and Observational Teamwork Assessments.
Conclusions
The SP robotic platform did not adversely affect human factor performance of the surgeon during RALP. Multi‐institutional validation will be necessary to confirm these initial findings.
Our aim was to evaluate the utility and effectiveness of a study protocol for neurological involvement in neurological disorders. We studied a sample of 786 patients with neurological disorders followed by the Neurological Department of Catania University and applied to them a four-step diagnostic protocol. Fifty-six per cent of the sample showed urological functional abnormalities; only 78 patients (9.9%) presented with an organic urological disease. Among the vesicosphincteric dysfunctions, bladder hyperreflexia was the most common pattern with remarkable differences between diseases. The present study demonstrated the utility of a standardized urological protocol in the screening and detection of neurological involvement in neurological diseases. Our protocol showed good specificity and reasonable low costs.
Over the years the treatment of induratio penis plastica has known many ups and downs, using many drugs administered in different ways (Potaba, vit. E, Nimesulide, Orgotein) associated or not with other drugs (Potassium iodide, Cortisone). Verapamil has been used in the last two years. It is a calcium antagonist drug commonly used by cardiologists in treating arrhythmia. It is administered by injection directly into the plaque at a dose of 5 mg a week and has given good results with regard to pain and curvature of the shaft during erection. We treated 40 patients from 1995 to 1997, 13 with injection into the plaque and 27 with a new method of drug transportation called cryoelectrophoresis. The physical principles of this method are referred to and the authors’ experience and results of IPP treatment are described.
Bladder vaginal fistulas are one of the most common urological pathologies. They are mostly of iatrogenic origin and are a great handicap, especially with regard to the quality of life of the patients. The authors report on the experience gained by working together with gynaecology departments, giving some case reports and the therapeutic strategies used.
Chemotherapy using drugs such as mitomycin C or epirubicin is well known in the treatment of superficial bladder tumours, while use of BCG (Bacillus Calmette-Guérin) in the same pathology is more recent. The first authors to test the BCG were Co? and Feldman, then Zbar fixed the criteria for correct use in the treatment of superficial bladder tumours. First results encouraged the preparation of a drug that could reduce the toxic effects without reducing demonstrated efficacy. Our experience started recently with the introduction onto the market of the Connaught strain, which we prefer to use due to its low toxic effects. We wish to evaluate the tolerability of BCG in a short follow-up period (six months) with cystoscopic controls.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.